Translations:Medication/151/en: Difference between revisions
Jump to navigation
Jump to search
Importing a new version from external source |
Importing a new version from external source |
||
| Line 1: | Line 1: | ||
[[Novartis|Novartis]] fought a protracted battle with the government of India over the patenting of its drug, [[Gleevec|Gleevec]], in India, which ended up in a Supreme Court in a case known as [[Novartis v. Union of India & Others|Novartis v. Union of India & Others]]. The Supreme Court ruled narrowly against Novartis, but opponents of patenting drugs claimed it as a major victory. | [[Novartis|Novartis]] fought a protracted battle with the government of India over the patenting of its drug, [[Gleevec|Gleevec]], in India, which ended up in a Supreme Court in a case known as [[:en:Novartis v. Union of India & Others|Novartis v. Union of India & Others]]. The Supreme Court ruled narrowly against Novartis, but opponents of patenting drugs claimed it as a major victory. | ||
Latest revision as of 07:47, 23 July 2023
Novartis fought a protracted battle with the government of India over the patenting of its drug, Gleevec, in India, which ended up in a Supreme Court in a case known as Novartis v. Union of India & Others. The Supreme Court ruled narrowly against Novartis, but opponents of patenting drugs claimed it as a major victory.